BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10499044)

  • 1. Second laryngeal cancers in previously treated larynges.
    McGuirt WF; Ray M
    Laryngoscope; 1999 Sep; 109(9):1406-8. PubMed ID: 10499044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second head and neck cancers and tobacco usage.
    Tomek MS; McGuirt WF
    Am J Otolaryngol; 2003; 24(1):24-7. PubMed ID: 12579479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignant neoplasms in patients under 40 years of age with laryngeal cancer.
    Albright JT; Karpati R; Topham AK; Spiegel JR; Sataloff RT
    Laryngoscope; 2001 Apr; 111(4 Pt 1):563-7. PubMed ID: 11359120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of the glottic larynx: the Christchurch experience.
    Allison RS; Wynne CJ; Stevenson DS; Tichener G
    N Z Med J; 1992 Jul; 105(937):256-7. PubMed ID: 1620509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
    B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High relative risk of a second pulmonary cancer in patients affected by laryngeal cancer: differences by specific site of occurrence and lung cancer histotype.
    Silvestri F; Bussani R; Cosatti C; Bosatra A
    Laryngoscope; 1994 Feb; 104(2):222-5. PubMed ID: 8302128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary neoplasms in patients with laryngeal carcinoma.
    Nikolaou AC; Markou CD; Petridis DG; Daniilidis IC
    Laryngoscope; 2000 Jan; 110(1):58-64. PubMed ID: 10646717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple primary malignant tumors of the larynx and lung].
    Croce A; Neri G; Moretti A; Bianchedi M
    G Chir; 1993 Sep; 14(7):354-8. PubMed ID: 8286179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
    Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
    Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of treatment results for oral tongue cancer.
    Sessions DG; Spector GJ; Lenox J; Haughey B; Chao C; Marks J
    Laryngoscope; 2002 Apr; 112(4):616-25. PubMed ID: 12150512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second primary lung cancer in laryngeal cancer patients: report on 36 cases].
    Gao Y; Wang L; Zhang D
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):341-3. PubMed ID: 11783123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.